Free Trial
→ $100 Trillion “AI Metal” Found in American Ghost Town (From Brownstone Research) (Ad) Free AKTX Stock Alerts

Akari Therapeutics (AKTX) SEC Filings & 10K Form

Akari Therapeutics logo
$1.00 -0.01 (-0.59%)
Closing price 08/4/2025 03:51 PM Eastern
Extended Trading
$0.70 -0.31 (-30.78%)
As of 08:07 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Akari Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
07/31/2025
11:15 PM		Akari Therapeutics (Filer)
Form EFFECT
07/29/2025
4:21 PM		Akari Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/29/2025
4:25 PM		Akari Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/01/2025
4:30 PM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2025
3:30 PM		Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
3:30 PM		Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
3:30 PM		Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
4:00 PM		Akari Therapeutics (Filer)
Form PRE 14A
05/15/2025
7:58 AM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
11:15 PM		Akari Therapeutics (Filer)
Form EFFECT
05/06/2025
4:23 PM		Akari Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/29/2025
4:00 PM		Akari Therapeutics (Issuer)
Patel Sandip I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
7:00 AM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2025
3:33 PM		Akari Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/24/2025
4:00 PM		Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:00 PM		Akari Therapeutics (Issuer)
Huh Hoyoung (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:00 PM		Akari Therapeutics (Issuer)
Hombeck Torsten (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:00 PM		Akari Therapeutics (Issuer)
Prudo-Chlebosz Raymond (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:00 PM		Akari Therapeutics (Issuer)
Patel Sandip I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:00 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:00 PM		Akari Therapeutics (Issuer)
Bazemore Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:00 PM		Akari Therapeutics (Issuer)
Neal James R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
7:50 AM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
4:00 PM		Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:00 PM		Akari Therapeutics (Issuer)
Bazemore Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:00 PM		Akari Therapeutics (Issuer)
Neal James R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:00 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:00 PM		Akari Therapeutics (Issuer)
Prudo-Chlebosz Raymond (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:00 PM		Akari Therapeutics (Issuer)
Huh Hoyoung (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
8:10 AM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2025
3:30 PM		Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4/A
01/13/2025
7:00 AM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
7:05 AM		Akari Therapeutics (Issuer)
Hombeck Torsten (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
7:05 AM		Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
4:30 PM		Akari Therapeutics (Issuer)
Neal James R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:30 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:30 PM		Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:30 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
3:30 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
3:30 PM		Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
3:30 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump set to Boost Social Security Checks by 400%? (Ad)

If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...

Click here to see the details because the stakes couldn't be any higher.
12/26/2024
3:30 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
3:30 PM		Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/26/2024
3:30 PM		Akari Therapeutics (Issuer)
Neal James R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
3:30 PM		Akari Therapeutics (Issuer)
Hombeck Torsten (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/18/2024
3:30 PM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2024
3:30 PM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
3:00 PM		Akari Therapeutics (Subject)
Patel Samir Rashmikant (Filed by)
Form SC 13D/A
12/03/2024
4:48 PM		Akari Therapeutics (Issuer)
Prudo-Chlebosz Raymond (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:50 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
3:30 PM		Akari Therapeutics (Issuer)
Huh Hoyoung (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/22/2024
3:30 PM		Akari Therapeutics (Issuer)
Neal James R (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/22/2024
3:30 PM		Akari Therapeutics (Issuer)
Patel Sandip I (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/19/2024
3:48 PM		Akari Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/18/2024
7:02 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
3:27 PM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
7:00 AM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
5:00 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
7:51 AM		Akari Therapeutics (Subject)
Form 425
10/14/2024
11:15 PM		Akari Therapeutics (Filer)
Form EFFECT
10/11/2024
3:52 PM		Akari Therapeutics (Filer)
Form 424B3
10/09/2024
3:27 PM		Akari Therapeutics (Filer)
Form S-4/A
10/04/2024
3:30 PM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
5:34 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
5:43 AM		Akari Therapeutics (Filer)
Form S-4/A
09/18/2024
3:34 PM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2024
3:36 PM		Akari Therapeutics (Issuer)
Bazemore Robert B (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/18/2024
3:40 PM		Akari Therapeutics (Issuer)
Bazemore Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2024
11:15 PM		Akari Therapeutics (Filer)
Form EFFECT
09/13/2024
4:30 PM		Akari Therapeutics (Filer)
Form S-4
Registration statement under Securities Act of 1933  
09/06/2024
4:23 PM		Akari Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/06/2024
4:07 PM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2024
3:30 PM		Akari Therapeutics (Filer)
Form 8-K/A
08/19/2024
3:30 PM		Akari Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/19/2024
3:15 PM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
3:15 PM		Akari Therapeutics (Filer)
Form NT 10-Q
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:AKTX) was last updated on 8/5/2025 by MarketBeat.com Staff
From Our Partners
BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here.
Crypto 101 Media | Sponsored
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...
Brownstone Research | Sponsored
Man Who Called Nvidia at $1.10 Says Buy This Now...
In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...
The Oxford Club | Sponsored
Wall Street Hates This Gold IRA Strategy—Here’s Why
What if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...
Advantage Gold | Sponsored
Crypto Income (almost instantly)
How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...
Awesomely, LLC | Sponsored
Digital Dollar Alert: Protect Your Wealth Before It’s Too Late
134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...
American Alternative | Sponsored
One stock to replace Nvidia
I'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...
InvestorPlace | Sponsored
Washington Thinks They Own Your Bank Account
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...
Priority Gold | Sponsored